Results from masitinib study AB12005 in pancreatic cancer have been presented at the 2021 ASCO Annual Meeting
10/06/2021 – AB Science today announced that results from masitinib study AB12005 in pancreatic cancer have been presented at the 2021 ASCO Annual Meeting